MARY GAFFNEY: Open Payments
NPI 1467569483 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,616 in 46 payments from 12 companies in 2025. Trend: 2023 $1,085 · 2024 $1,085 · 2025 $1,616
Food & beverage: $1,348Education: $268
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $495 |
| AstraZeneca Pharmaceuticals LP | 3 | $415 |
| Lilly USA, LLC | 10 | $187 |
| Novo Nordisk Inc | 3 | $156 |
| Orexo US, Inc. | 5 | $104 |
| PFIZER INC. | 4 | $79 |
| Indivior Inc. | 2 | $48 |
| BioWound Solutions, Inc. | 1 | $36 |
| Amgen Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $28 |
Products named: AUSTEDO XR, BREZTRI, FARXIGA, Wegovy, MOUNJARO, Zubsolv, SUBLOCADE, NURTEC ODT.
Industry payments across NC — which companies pay providers there.
